These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 23842012

  • 1. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
    Nielsen J, Correll CU, Manu P, Kane JM.
    J Clin Psychiatry; 2013 Jun; 74(6):603-13; quiz 613. PubMed ID: 23842012
    [Abstract] [Full Text] [Related]

  • 2. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P, Lapitskaya Y, Shaikh A, Nielsen J.
    Am J Ther; 2018 Jun; 25(2):e218-e223. PubMed ID: 29505490
    [Abstract] [Full Text] [Related]

  • 3. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
    Manu P, Sarpal D, Muir O, Kane JM, Correll CU.
    Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clozapine and Fever: A Case of Continued Therapy With Clozapine.
    Bruno V, Valiente-Gómez A, Alcoverro O.
    Clin Neuropharmacol; 2015 Feb; 38(4):151-3. PubMed ID: 26166236
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
    Corbeil O, Béchard L, Fournier É, Plante M, Thivierge MA, Lafrenière CÉ, Huot-Lavoie M, Brodeur S, Essiambre AM, Roy MA, Demers MF.
    J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients.
    Davis MC, Fuller MA, Strauss ME, Konicki PE, Jaskiw GE.
    Acta Psychiatr Scand; 2014 Jul; 130(1):30-9. PubMed ID: 24299466
    [Abstract] [Full Text] [Related]

  • 18. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
    Huang TL.
    Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
    [Abstract] [Full Text] [Related]

  • 19. Clozapine safety, 40 years later.
    Raja M, Raja S.
    Curr Drug Saf; 2014 Aug; 9(3):163-95. PubMed ID: 24809463
    [Abstract] [Full Text] [Related]

  • 20. Adverse cardiac effects associated with clozapine.
    Merrill DB, Dec GW, Goff DC.
    J Clin Psychopharmacol; 2005 Feb; 25(1):32-41. PubMed ID: 15643098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.